Go Pro

LENSAR (LNSR) Financials

LENSAR logo
$5.67 0.00 (0.00%)
Closing price 07/16/2026 04:00 PM Eastern
Extended Trading
$5.68 +0.00 (+0.09%)
As of 07/16/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for LENSAR

Annual Income Statements for LENSAR

This table shows LENSAR's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-15 -20 -20 -20 -14 -31 -34
Consolidated Net Income / (Loss)
-15 -20 -20 -20 -14 -31 -34
Net Income / (Loss) Continuing Operations
-15 -20 -20 -20 -14 -31 -34
Total Pre-Tax Income
-15 -20 -20 -20 -15 -32 -35
Total Operating Income
-13 -19 -20 -20 -12 -11 -25
Total Gross Profit
13 14 18 20 21 26 27
Total Revenue
31 26 34 35 42 53 58
Operating Revenue
31 26 34 35 42 53 58
Total Cost of Revenue
17 12 17 15 21 28 31
Operating Cost of Revenue
17 12 17 15 21 28 31
Total Operating Expenses
26 33 37 40 33 37 52
Selling, General & Admin Expense
17 24 24 27 26 26 45
Research & Development Expense
7.57 7.55 12 12 6.14 5.33 5.62
Amortization Expense
1.23 1.26 1.24 1.15 1.10 0.97 0.92
Impairment Charge
- - - - 0.00 3.73 0.00
Total Other Income / (Expense), net
-2.00 -1.34 0.05 0.00 -2.85 -21 -10
Other Income / (Expense), net
- - 0.05 0.00 -2.85 -21 -10
Other Gains / (Losses), net
0.06 0.07 - 0.26 0.70 0.66 0.64
Basic Earnings per Share
($13.70) ($4.28) ($2.09) ($1.96) ($1.31) ($2.73) ($2.87)
Weighted Average Basic Shares Outstanding
1.07M 4.62M 9.37M 10.16M 10.97M 11.52M 11.96M
Diluted Earnings per Share
($13.70) ($4.28) ($2.09) ($1.96) ($1.31) ($2.73) ($2.87)
Weighted Average Diluted Shares Outstanding
1.07M 4.62M 9.37M 10.16M 10.97M 11.52M 11.96M
Weighted Average Basic & Diluted Shares Outstanding
1.07M 4.62M 9.37M 11.10M 11.40M 11.79M 12.10M

Quarterly Income Statements for LENSAR

This table shows LENSAR's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
2.57 -3.93 -2.16 -9.04 -1.50 -19 -27 -1.76 -3.71 -1.46 36
Consolidated Net Income / (Loss)
2.57 -3.93 -2.16 -9.04 -1.50 -19 -27 -1.76 -3.71 -1.46 36
Net Income / (Loss) Continuing Operations
2.57 -3.93 -2.16 -9.04 -1.50 -19 -27 -1.76 -3.71 -1.46 36
Total Pre-Tax Income
2.30 -4.16 -2.36 -9.20 -1.66 -19 -28 -1.96 -3.85 -1.61 36
Total Operating Income
-2.04 -2.96 -2.85 -5.28 -1.25 -1.29 -5.79 -6.29 -7.58 -4.92 2.24
Total Gross Profit
4.88 5.15 5.66 6.81 6.27 7.11 7.13 7.02 6.04 6.94 6.38
Total Revenue
9.80 12 11 13 14 17 14 14 14 16 13
Operating Revenue
9.80 12 11 13 14 17 14 14 14 16 13
Total Cost of Revenue
4.92 6.96 4.92 5.82 7.27 9.62 7.03 6.91 8.28 9.09 7.05
Total Operating Expenses
6.92 8.11 8.51 12 7.51 8.40 13 13 14 12 4.14
Selling, General & Admin Expense
5.12 6.37 6.80 6.78 6.08 6.83 11 12 12 10 2.53
Research & Development Expense
1.53 1.46 1.44 1.35 1.20 1.34 1.53 1.43 1.37 1.30 1.39
Amortization Expense
0.27 0.27 0.27 0.23 0.23 0.23 0.23 0.23 0.23 0.23 0.23
Impairment Charge
0.00 - - 3.73 0.00 - 0.00 0.00 0.00 - 0.00
Total Other Income / (Expense), net
4.34 -1.20 0.50 -3.92 -0.41 -18 -22 4.33 3.73 3.31 34
Interest & Investment Income
- - - - - - - - - - 10
Other Income / (Expense), net
4.34 -1.20 0.50 -3.92 -0.41 -18 -22 4.33 3.73 3.31 24
Basic Earnings per Share
$0.13 ($0.23) ($0.19) ($0.79) ($0.13) ($1.62) ($2.32) ($0.15) ($0.31) ($0.09) $1.56
Weighted Average Basic Shares Outstanding
11.10M 10.97M 11.39M 11.45M 11.60M 11.52M 11.77M 11.94M 12.04M 11.96M 12.16M
Diluted Earnings per Share
($0.23) $0.13 ($0.19) ($0.79) ($0.13) ($1.62) ($2.32) ($0.15) ($0.31) ($0.09) $0.00
Weighted Average Diluted Shares Outstanding
11.96M 10.97M 11.39M 11.45M 11.60M 11.52M 11.77M 11.94M 12.04M 11.96M 15.42M
Weighted Average Basic & Diluted Shares Outstanding
11.25M 11.40M 11.40M 11.61M 11.61M 11.79M 11.79M 11.93M 11.94M 12.10M 12.10M

Annual Cash Flow Statements for LENSAR

This table details how cash moves in and out of LENSAR's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
1.27 36 -8.96 -17 5.95 -4.36 -3.29
Net Cash From Operating Activities
-13 -14 -8.97 -15 -9.66 -2.28 -15
Net Cash From Continuing Operating Activities
-13 -14 -8.97 -15 -9.66 -2.28 -15
Net Income / (Loss) Continuing Operations
-15 -20 -20 -20 -14 -31 -34
Consolidated Net Income / (Loss)
-15 -20 -20 -20 -14 -31 -34
Depreciation Expense
2.64 1.31 1.52 2.26 2.42 2.96 3.58
Amortization Expense
1.23 1.76 1.24 1.15 1.09 0.72 0.74
Non-Cash Adjustments To Reconcile Net Income
0.56 9.09 7.91 7.23 9.00 28 14
Changes in Operating Assets and Liabilities, net
-2.36 -6.19 -0.04 -5.58 -7.78 -2.48 1.10
Net Cash From Investing Activities
-2.09 -0.33 -0.35 -0.12 -4.16 -2.16 1.28
Net Cash From Continuing Investing Activities
-2.09 -0.33 -0.35 -0.12 -4.16 -2.16 1.28
Purchase of Property, Plant & Equipment
-0.39 -0.37 -0.35 -0.12 -0.24 -0.16 -0.08
Purchase of Investments
- - - 0.00 -3.92 -10 -12
Sale and/or Maturity of Investments
- - - - 0.00 8.24 13
Net Cash From Financing Activities
16 50 0.36 -1.99 20 0.08 10
Net Cash From Continuing Financing Activities
16 50 0.36 -1.99 20 0.08 10
Repurchase of Preferred Equity
- - - - 0.00 -0.10 0.00
Issuance of Preferred Equity
- - - 0.00 14 0.00 0.00
Issuance of Common Equity
0.00 16 0.36 0.41 5.93 0.31 0.59
Other Financing Activities, net
2.76 23 0.00 -2.40 -0.05 -0.13 9.67
Cash Interest Paid
0.47 0.48 0.00 0.00 0.00 0.00 0.00
Cash Income Taxes Paid
- 0.00 0.02 0.00 0.02 0.02 0.04

Quarterly Cash Flow Statements for LENSAR

This table details how cash moves in and out of LENSAR's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-0.55 -4.30 -6.66 -5.67 2.16 5.82 3.28 -12 0.49 5.34 -0.48
Net Cash From Operating Activities
-0.34 -0.48 -5.31 -3.78 3.15 3.66 -6.94 -5.00 -3.51 0.62 -4.27
Net Cash From Continuing Operating Activities
-0.34 -0.48 -5.31 -3.78 3.15 3.66 -6.94 -5.00 -3.51 0.62 -4.27
Net Income / (Loss) Continuing Operations
2.57 -3.93 -2.16 -9.04 -1.50 -19 -27 -1.76 -3.71 -1.46 36
Consolidated Net Income / (Loss)
2.57 -3.93 -2.16 -9.04 -1.50 -19 -27 -1.76 -3.71 -1.46 36
Depreciation Expense
0.61 0.65 0.65 0.67 0.77 0.87 0.84 0.87 0.93 0.94 0.90
Amortization Expense
0.27 0.26 0.22 0.16 0.17 0.17 0.19 0.18 0.16 0.21 0.23
Non-Cash Adjustments To Reconcile Net Income
-2.97 2.16 0.44 8.20 1.05 18 23 -3.75 -2.52 -2.25 -33
Changes in Operating Assets and Liabilities, net
-0.82 0.37 -4.46 -3.77 2.67 3.49 -3.16 -0.53 1.62 3.17 -8.65
Net Cash From Investing Activities
-0.00 -3.97 -1.23 -2.02 -0.91 1.99 0.53 -7.49 4.00 4.25 4.00
Net Cash From Continuing Investing Activities
-0.00 -3.97 -1.23 -2.02 -0.91 1.99 0.53 -7.49 4.00 4.25 4.00
Purchase of Property, Plant & Equipment
-0.00 -0.05 -0.02 -0.11 -0.02 -0.00 -0.01 -0.08 - - 0.00
Purchase of Investments
- -3.92 -2.21 -3.91 -4.13 - -2.96 -8.92 - - 0.00
Sale and/or Maturity of Investments
- - 1.00 2.00 3.25 2.00 3.50 1.50 4.00 4.25 4.00
Net Cash From Financing Activities
-0.21 0.15 -0.13 0.13 -0.09 0.17 9.69 0.09 - 0.47 -0.21
Net Cash From Continuing Financing Activities
-0.21 0.15 -0.13 0.13 -0.09 0.17 9.69 0.09 - 0.47 -0.21
Other Financing Activities, net
-0.05 - -0.08 0.01 -0.09 0.04 9.69 -0.08 - 0.06 -0.21
Cash Interest Paid
- - 0.01 -0.01 - - 0.00 -0.00 - - 0.00

Annual Balance Sheets for LENSAR

This table presents LENSAR's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
35 79 66 56 70 66 71
Total Current Assets
17 58 45 34 46 42 47
Cash & Equivalents
4.62 41 32 15 21 16 13
Short-Term Investments
- - - 0.00 3.44 6.19 5.00
Note & Lease Receivable
0.50 0.44 0.35 0.20 0.32 0.40 0.30
Accounts Receivable
3.38 2.01 4.64 6.04 4.00 6.09 6.38
Inventories, net
8.06 13 6.49 12 16 11 22
Prepaid Expenses
0.62 1.86 1.70 1.06 2.37 1.62 0.60
Plant, Property, & Equipment, net
0.72 0.83 0.76 0.56 0.68 0.66 0.51
Total Noncurrent Assets
17 20 21 22 22 24 24
Noncurrent Note & Lease Receivables
0.83 0.45 0.12 6.76 1.28 15 16
Intangible Assets
13 12 11 12 11 6.11 5.19
Other Noncurrent Operating Assets
2.44 7.34 9.91 2.69 9.67 2.62 2.75
Total Liabilities & Shareholders' Equity
35 79 66 56 70 66 71
Total Liabilities
65 12 12 14 22 48 84
Total Current Liabilities
7.83 8.47 8.71 11 12 15 41
Accounts Payable
1.58 2.48 2.69 5.42 4.01 6.00 19
Accrued Expenses
4.78 4.57 4.60 4.70 5.72 6.81 7.77
Customer Deposits
- - - - - 0.00 10
Current Deferred Revenue
0.78 0.92 0.90 0.77 1.35 1.68 3.07
Other Current Liabilities
0.70 0.49 0.51 0.53 0.56 0.52 0.75
Total Noncurrent Liabilities
57 3.44 2.87 2.44 11 33 43
Long-Term Debt
- - - - - - 0.00
Other Noncurrent Operating Liabilities
37 3.44 2.87 2.44 11 33 43
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
- - - 0.00 14 14 14
Total Equity & Noncontrolling Interests
-31 67 55 42 33 4.86 -26
Total Preferred & Common Equity
-31 67 55 42 33 4.86 -26
Preferred Stock
- 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-31 67 55 42 33 4.86 -26
Common Stock
7.63 125 132 139 145 148 152
Retained Earnings
-38 -58 -78 -98 -112 -143 -178
Accumulated Other Comprehensive Income / (Loss)
- - - 0.00 0.00 0.01 0.00

Quarterly Balance Sheets for LENSAR

This table presents LENSAR's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
71 66 61 62 73 70 70 66
Total Current Assets
49 42 40 39 49 46 44 42
Cash & Equivalents
25 14 8.29 10 20 7.15 7.64 12
Short-Term Investments
- 3.95 5.93 7.64 5.70 13 9.23 1.00
Note & Lease Receivable
0.26 0.33 0.34 0.35 0.36 0.34 0.29 0.29
Accounts Receivable
3.85 4.02 5.89 4.37 6.89 4.99 5.90 4.90
Inventories, net
17 18 18 15 15 19 21 23
Prepaid Expenses
2.13 2.36 1.85 1.71 1.37 0.99 0.78 0.63
Plant, Property, & Equipment, net
0.48 0.75 0.72 0.68 0.58 0.61 0.56 0.46
Total Noncurrent Assets
22 23 20 22 23 24 25 23
Noncurrent Note & Lease Receivables
8.09 8.90 11 0.95 15 16 17 16
Intangible Assets
11 11 6.58 6.34 5.88 5.65 5.42 4.96
Other Noncurrent Operating Assets
2.34 2.06 1.97 14 2.48 2.35 2.93 2.55
Total Liabilities & Shareholders' Equity
71 66 61 62 73 70 70 66
Total Liabilities
21 21 24 25 81 80 82 42
Total Current Liabilities
11 10 10 12 27 30 36 18
Accounts Payable
3.94 4.12 4.12 3.87 7.75 11 15 10
Accrued Expenses
5.46 4.18 4.26 5.80 6.91 5.73 7.89 3.90
Customer Deposits
- - - - 10 10 10 0.00
Current Deferred Revenue
1.06 1.58 1.41 1.44 1.99 2.53 2.34 3.01
Other Current Liabilities
0.55 0.56 0.57 0.57 0.52 0.52 0.69 0.79
Total Noncurrent Liabilities
9.71 10 14 14 54 50 47 24
Long-Term Debt
- - - - - - - 5.00
Other Noncurrent Operating Liabilities
9.71 10 14 14 54 50 47 19
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
14 14 14 14 14 14 14 14
Total Equity & Noncontrolling Interests
36 32 24 23 -22 -23 -26 11
Total Preferred & Common Equity
36 32 24 23 -22 -23 -26 11
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
36 32 24 23 -22 -23 -26 11
Common Stock
144 146 147 147 148 149 150 152
Retained Earnings
-108 -114 -123 -125 -171 -172 -176 -141
Accumulated Other Comprehensive Income / (Loss)
- -0.00 -0.01 0.02 0.00 -0.00 0.01 0.00

Annual Metrics And Ratios for LENSAR

This table displays calculated financial ratios and metrics derived from LENSAR's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 10,638,819.00 10,956,688.00 11,023,304.00 11,248,507.00 - 11,944,546.00
DEI Adjusted Shares Outstanding
0.00 10,638,819.00 10,956,688.00 11,023,304.00 11,248,507.00 - 11,944,546.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 -1.86 -1.79 -1.81 -1.28 - -2.87
Growth Metrics
- - - - - - -
Revenue Growth
0.00% -13.58% 30.62% 2.61% 19.25% 26.87% 9.24%
EBITDA Growth
0.00% -74.41% -9.10% 0.39% 30.96% -145.15% -7.79%
EBIT Growth
0.00% -45.52% -5.94% -2.94% 25.26% -112.61% -8.89%
NOPAT Growth
0.00% -45.52% -6.22% -2.67% 39.39% 12.79% -130.45%
Net Income Growth
0.00% -34.91% 0.87% -1.60% 27.77% -118.34% -9.16%
EPS Growth
0.00% 68.76% 51.17% 6.22% 33.16% -108.40% -5.13%
Operating Cash Flow Growth
0.00% -9.55% 34.96% -65.64% 34.98% 76.45% -551.91%
Free Cash Flow Firm Growth
0.00% 0.00% 80.95% -75.13% 78.73% 589.97% -51.49%
Invested Capital Growth
0.00% 277.79% -12.66% 17.50% -17.17% -116.84% -693.20%
Revenue Q/Q Growth
0.00% 0.00% -4.54% -2.72% 4.65% 9.47% -1.19%
EBITDA Q/Q Growth
0.00% 0.00% 13.67% 7.61% -37.23% -105.38% 36.20%
EBIT Q/Q Growth
0.00% 0.00% 13.22% 6.05% -26.93% -84.57% 33.06%
NOPAT Q/Q Growth
0.00% 0.00% 13.00% 6.05% -2.93% 13.55% -17.32%
Net Income Q/Q Growth
0.00% 0.00% 12.99% 6.62% -11.09% -88.86% 33.47%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 21.56% -178.57% 34.77%
Operating Cash Flow Q/Q Growth
0.00% 25.74% 12.30% -37.09% 30.70% 64.52% -25.77%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% -33.59% 62.19% 1,480.97% -71.50%
Invested Capital Q/Q Growth
0.00% 0.00% -5.92% 17.26% -10.27% -121.22% -4.21%
Profitability Metrics
- - - - - - -
Gross Margin
43.33% 53.35% 51.75% 56.44% 50.06% 48.33% 46.41%
EBITDA Margin
-28.98% -58.49% -48.86% -47.43% -27.46% -53.06% -52.36%
Operating Margin
-41.65% -70.13% -57.03% -57.06% -29.00% -19.94% -42.06%
EBIT Margin
-41.65% -70.13% -56.88% -57.06% -35.77% -59.94% -59.75%
Profit (Net Income) Margin
-48.01% -74.95% -56.88% -56.32% -34.11% -58.71% -58.66%
Tax Burden Percent
99.61% 99.66% 100.00% 98.70% 95.37% 97.94% 98.18%
Interest Burden Percent
115.74% 107.24% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% -222.48% -55.19% -55.88% -34.29% -79.37% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -167.93% -39.01% -30.87% -4.60% 22.47% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 114.59% 23.08% 14.76% 2.03% -16.05% 0.00%
Return on Equity (ROE)
47.97% -107.89% -32.11% -41.12% -32.26% -95.42% -1,069.41%
Cash Return on Invested Capital (CROIC)
0.00% -204.92% -41.67% -71.97% -15.50% 0.00% 0.00%
Operating Return on Assets (OROA)
-36.81% -32.56% -26.93% -32.99% -24.05% -47.19% -50.70%
Return on Assets (ROA)
-42.44% -34.80% -26.93% -32.56% -22.93% -46.22% -49.78%
Return on Common Equity (ROCE)
47.97% -107.89% -32.11% -41.12% -27.29% -55.51% 3,529.18%
Return on Equity Simple (ROE_SIMPLE)
47.97% -29.42% -35.72% -47.43% -43.03% -645.91% 0.00%
Net Operating Profit after Tax (NOPAT)
-8.90 -13 -14 -14 -8.56 -7.47 -17
NOPAT Margin
-29.15% -49.09% -39.92% -39.95% -20.30% -13.96% -29.44%
Net Nonoperating Expense Percent (NNEP)
36.94% -54.55% -16.18% -25.01% -29.68% -101.84% -84.46%
Return On Investment Capital (ROIC_SIMPLE)
- - - - -25.61% -153.55% 66.12%
Cost of Revenue to Revenue
56.67% 46.65% 48.25% 43.56% 49.94% 51.68% 53.59%
SG&A Expenses to Revenue
56.17% 90.09% 69.32% 76.84% 61.90% 49.52% 77.28%
R&D to Revenue
24.79% 28.63% 35.86% 33.41% 14.56% 9.96% 9.62%
Operating Expenses to Revenue
84.98% 123.48% 108.78% 113.50% 79.06% 68.26% 88.47%
Earnings before Interest and Taxes (EBIT)
-13 -19 -20 -20 -15 -32 -35
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-8.85 -15 -17 -17 -12 -28 -31
Valuation Ratios
- - - - - - -
Price to Book Value (P/BV)
0.00 1.15 1.20 0.78 1.18 21.36 0.00
Price to Tangible Book Value (P/TBV)
0.00 1.40 1.49 1.09 1.76 0.00 0.00
Price to Revenue (P/Rev)
0.00 2.92 1.90 0.92 0.94 1.94 2.38
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 1.37 1.46 0.66 1.27 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 1.38 0.99 0.51 0.68 1.78 2.31
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 5.02 14.64
Leverage & Solvency
- - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.51 -0.68 -0.59 -0.48 -0.44 -0.71 -6.31
Leverage Ratio
-1.13 3.10 1.19 1.26 1.41 2.06 21.48
Compound Leverage Factor
-1.31 3.33 1.19 1.26 1.41 2.06 21.48
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 29.14% 73.92% -112.66%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 70.86% 26.08% 212.66%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
0.00 3.18 1.96 -1.11 -0.70 -2.02 -3.18
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 15.42% 41.83% 430.01%
Liquidity Ratios
- - - - - - -
Current Ratio
2.19 6.90 5.14 2.95 3.99 2.80 1.15
Quick Ratio
1.09 5.09 4.20 1.83 2.44 1.93 0.61
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -55 -10 -18 -3.87 19 9.20
Operating Cash Flow to CapEx
-3,236.25% -4,230.37% -2,533.62% -12,918.26% -4,092.80% -1,458.33% -17,868.67%
Free Cash Flow to Firm to Interest Expense
0.00 -40.69 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
-6.29 -10.29 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-6.49 -10.54 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - -
Asset Turnover
0.88 0.46 0.47 0.58 0.67 0.79 0.85
Accounts Receivable Turnover
9.02 9.78 10.36 6.62 8.40 10.61 9.38
Inventory Turnover
2.15 1.14 1.67 1.69 1.54 2.04 1.90
Fixed Asset Turnover
42.40 34.00 43.40 53.61 67.90 79.66 99.97
Accounts Payable Turnover
10.97 6.07 6.43 3.80 4.47 5.53 2.51
Days Sales Outstanding (DSO)
40.46 37.33 35.22 55.11 43.46 34.41 38.92
Days Inventory Outstanding (DIO)
170.15 319.37 219.11 215.97 237.73 179.03 192.03
Days Payable Outstanding (DPO)
33.27 60.18 56.80 96.16 81.72 66.03 145.57
Cash Conversion Cycle (CCC)
177.33 296.52 197.52 174.92 199.47 147.40 85.38
Capital & Investment Metrics
- - - - - - -
Invested Capital
-15 27 23 27 23 -3.81 -30
Invested Capital Turnover
-2.04 4.53 1.38 1.40 1.69 5.69 -3.44
Increase / (Decrease) in Invested Capital
0.00 42 -3.37 4.07 -4.69 -26 -26
Enterprise Value (EV)
0.00 37 34 18 29 95 135
Market Capitalization
0.00 77 66 33 39 104 139
Book Value per Share
($28.55) $6.32 $5.01 $3.81 $2.97 $0.42 ($2.18)
Tangible Book Value per Share
($41.05) $5.18 $4.02 $2.71 $1.99 ($0.11) ($2.61)
Total Capital
-31 67 55 42 47 19 -12
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-4.62 -41 -32 -15 -25 -22 -18
Capital Expenditures (CapEx)
0.39 0.33 0.35 0.12 0.24 0.16 0.08
Debt-free, Cash-free Net Working Capital (DFCFNWC)
4.74 9.32 4.46 7.62 11 4.52 -12
Debt-free Net Working Capital (DFNWC)
9.35 50 36 22 35 27 6.20
Net Working Capital (NWC)
9.35 50 36 22 35 27 6.20
Net Nonoperating Expense (NNE)
5.76 6.82 5.84 5.79 5.82 24 17
Net Nonoperating Obligations (NNO)
16 -41 -32 -15 -25 -22 -18
Total Depreciation and Amortization (D&A)
3.87 3.07 2.76 3.41 3.50 3.68 4.32
Debt-free, Cash-free Net Working Capital to Revenue
15.52% 35.32% 12.95% 21.55% 25.49% 8.45% -20.16%
Debt-free Net Working Capital to Revenue
30.64% 189.21% 104.76% 63.06% 82.56% 50.43% 10.60%
Net Working Capital to Revenue
30.64% 189.21% 104.76% 63.06% 82.56% 50.43% 10.60%
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 ($4.28) ($2.09) ($1.96) ($1.31) ($2.73) ($2.87)
Adjusted Weighted Average Basic Shares Outstanding
0.00 10.93M 10.99M 10.16M 10.97M 11.52M 11.96M
Adjusted Diluted Earnings per Share
$0.00 ($4.28) ($2.09) ($1.96) ($1.31) ($2.73) ($2.87)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 10.93M 10.99M 10.16M 10.97M 11.52M 11.96M
Adjusted Basic & Diluted Earnings per Share
$0.00 ($4.28) ($2.09) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 4.62M 9.37M 11.10M 11.40M 11.79M 12.10M
Normalized Net Operating Profit after Tax (NOPAT)
-8.90 -13 -14 -14 -8.56 -4.86 -17
Normalized NOPAT Margin
-29.15% -49.09% -39.92% -39.95% -20.30% -9.08% -29.44%
Pre Tax Income Margin
-48.20% -75.21% -56.88% -57.06% -35.77% -59.94% -59.75%
Debt Service Ratios
- - - - - - -
EBIT to Interest Expense
-6.35 -13.81 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
-4.45 -9.67 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-6.55 -14.05 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-4.64 -9.91 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - -
Dividend Payout Ratio
-0.21% -9.42% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-0.21% -9.42% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for LENSAR

This table displays calculated financial ratios and metrics derived from LENSAR's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
11,246,205.00 11,248,507.00 11,395,056.00 11,396,950.00 11,608,415.00 - 11,789,492.00 11,792,156.00 11,934,784.00 11,944,546.00 12,095,631.00
DEI Adjusted Shares Outstanding
11,246,205.00 11,248,507.00 11,395,056.00 11,396,950.00 11,608,415.00 - 11,789,492.00 11,792,156.00 11,934,784.00 11,944,546.00 12,095,631.00
DEI Earnings Per Adjusted Shares Outstanding
0.23 -0.35 -0.19 -0.79 -0.13 - -2.32 -0.15 -0.31 -0.12 3.00
Growth Metrics
- - - - - - - - - - -
Revenue Growth
26.42% 18.31% 28.31% 5.19% 38.22% 38.22% 33.73% 10.28% 5.74% -4.22% -5.16%
EBITDA Growth
198.42% -84.49% 57.66% -4.56% -122.42% -448.51% -1,682.83% 89.10% -285.71% 97.46% 203.74%
EBIT Growth
156.40% -59.17% 46.00% -3.82% -171.86% -353.26% -1,067.90% 78.74% -132.39% 91.46% 195.74%
NOPAT Growth
28.62% -13.32% 34.65% -84.16% 57.28% 56.43% -103.16% -19.11% -508.84% -281.32% 155.24%
Net Income Growth
164.34% -57.67% 49.51% -3.31% -158.49% -376.36% -1,167.73% 80.49% -147.20% 92.20% 232.87%
EPS Growth
41.03% 156.52% 52.50% 2.47% 43.48% -1,346.15% -1,121.05% 81.01% -138.46% 94.44% 100.00%
Operating Cash Flow Growth
92.79% 89.91% 20.74% -76.21% 1,030.09% 861.88% -30.73% -32.29% -211.42% -83.10% 38.44%
Free Cash Flow Firm Growth
-174.41% 144.38% 122.18% -43.86% 261.38% 875.28% 1,743.50% 1,101.84% 551.50% -10.05% -184.74%
Invested Capital Growth
8.24% -17.17% -15.99% 4.82% -28.81% -116.84% -227.11% -234.55% -261.53% -693.20% 147.85%
Revenue Q/Q Growth
-18.46% 23.58% -12.53% 19.34% 7.15% 23.58% -15.37% -1.58% 2.73% 11.94% -16.21%
EBITDA Q/Q Growth
139.77% -201.95% 54.27% -463.91% 91.47% -2,394.40% -48.65% 96.55% -201.64% 83.55% 6,162.91%
EBIT Q/Q Growth
125.98% -280.59% 43.38% -290.79% 82.02% -1,039.03% -45.90% 92.88% -96.53% 58.16% 1,736.54%
NOPAT Q/Q Growth
-1.65% -1.60% 3.75% -85.26% 76.42% -3.61% -348.84% -8.62% -20.53% 35.11% 165.02%
Net Income Q/Q Growth
129.34% -252.88% 45.06% -319.24% 83.39% -1,145.14% -46.21% 93.55% -110.49% 60.73% 2,591.91%
EPS Q/Q Growth
71.60% 156.52% -246.15% -315.79% 83.54% -1,146.15% -43.21% 93.53% -106.67% 70.97% 100.00%
Operating Cash Flow Q/Q Growth
84.19% -41.59% -1,005.63% 28.81% 183.46% 15.98% -289.72% 27.96% 29.71% 117.59% -791.10%
Free Cash Flow Firm Q/Q Growth
-21.03% 166.09% 16.04% -254.99% 235.77% 299.44% 119.33% -15.77% -11.71% -44.85% -306.63%
Invested Capital Q/Q Growth
20.21% -10.27% 16.87% -16.85% -18.35% -121.22% -782.23% 11.98% 1.98% -4.21% 153.22%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
49.79% 42.54% 53.49% 53.92% 46.28% 42.48% 50.32% 50.41% 42.16% 43.29% 47.53%
EBITDA Margin
32.52% -26.82% -14.03% -66.27% -5.27% -106.45% -186.98% -6.55% -19.24% -2.83% 204.54%
Operating Margin
-20.83% -24.46% -26.92% -41.79% -9.20% -7.71% -40.89% -45.13% -52.95% -30.70% 16.67%
EBIT Margin
23.51% -34.36% -22.24% -72.83% -12.22% -112.67% -194.25% -14.04% -26.87% -10.04% 196.10%
Profit (Net Income) Margin
26.22% -32.43% -20.37% -71.57% -11.09% -111.78% -193.13% -12.66% -25.94% -9.10% 270.57%
Tax Burden Percent
111.51% 94.40% 91.59% 98.26% 90.76% 99.21% 99.42% 90.14% 96.54% 90.62% 100.00%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 137.98%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-34.60% -28.92% -28.96% -61.46% -14.58% -30.70% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-55.45% -19.47% -27.77% -35.32% -11.68% 45.03% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
26.44% 8.57% 8.86% 17.23% 5.86% -32.16% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-8.16% -20.35% -20.11% -44.23% -8.72% -62.85% -304.05% -350.22% -422.35% -1,069.41% 362.55%
Cash Return on Invested Capital (CROIC)
-42.21% -15.50% -8.53% -47.51% -6.36% 0.00% 0.00% 0.00% 0.00% 0.00% -411.92%
Operating Return on Assets (OROA)
15.08% -23.10% -16.76% -49.57% -8.99% -88.71% -159.39% -12.44% -24.03% -8.52% 162.60%
Return on Assets (ROA)
16.81% -21.81% -15.35% -48.71% -8.16% -88.01% -158.47% -11.21% -23.20% -7.72% 224.35%
Return on Common Equity (ROCE)
-6.95% -17.21% -16.85% -29.71% -5.95% -36.56% -79.18% -7.37% 54.86% 3,529.18% -253.76%
Return on Equity Simple (ROE_SIMPLE)
-35.59% 0.00% -38.54% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-2.04 -2.07 -2.00 -3.70 -0.87 -0.90 -4.05 -4.40 -5.31 -3.44 2.24
NOPAT Margin
-20.83% -17.12% -18.84% -29.25% -6.44% -5.40% -28.62% -31.59% -37.06% -21.49% 16.67%
Net Nonoperating Expense Percent (NNEP)
20.84% -9.45% -1.19% -26.14% -2.90% -75.72% -104.94% 14.76% 8.99% 9.82% 202.08%
Return On Investment Capital (ROIC_SIMPLE)
- -6.20% -6.27% -15.63% -3.83% -18.57% 18.31% 19.10% 20.48% 13.23% 14.18%
Cost of Revenue to Revenue
50.21% 57.46% 46.51% 46.08% 53.72% 57.52% 49.68% 49.59% 57.84% 56.71% 52.47%
SG&A Expenses to Revenue
52.24% 52.66% 64.19% 53.69% 44.89% 40.83% 78.74% 83.66% 83.96% 64.46% 18.83%
R&D to Revenue
15.59% 12.09% 13.64% 10.67% 8.88% 7.98% 10.83% 10.23% 9.55% 8.09% 10.31%
Operating Expenses to Revenue
70.62% 67.00% 80.41% 95.70% 55.48% 50.19% 91.21% 95.54% 95.11% 73.98% 30.85%
Earnings before Interest and Taxes (EBIT)
2.30 -4.16 -2.36 -9.20 -1.66 -19 -28 -1.96 -3.85 -1.61 26
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
3.19 -3.25 -1.49 -8.37 -0.71 -18 -26 -0.91 -2.75 -0.45 27
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.96 1.18 1.22 2.17 2.34 21.36 0.00 0.00 0.00 0.00 6.68
Price to Tangible Book Value (P/TBV)
1.39 1.76 1.84 3.00 3.24 0.00 0.00 0.00 0.00 0.00 12.37
Price to Revenue (P/Rev)
0.86 0.94 0.87 1.14 1.09 1.94 2.92 2.66 2.49 2.38 1.25
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.45
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 40.78%
Enterprise Value to Invested Capital (EV/IC)
0.94 1.27 1.26 2.26 2.70 0.00 0.00 0.00 0.00 0.00 4.81
Enterprise Value to Revenue (EV/Rev)
0.59 0.68 0.75 1.10 0.99 1.78 2.72 2.55 2.44 2.31 1.34
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.31
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.09
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 5.02 3.07 3.60 4.47 14.64 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.20
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.20
Financial Leverage
-0.48 -0.44 -0.32 -0.49 -0.50 -0.71 -1.19 -1.27 -1.45 -6.31 -2.08
Leverage Ratio
1.36 1.41 1.39 1.58 1.53 2.06 3.74 4.68 5.42 21.48 8.58
Compound Leverage Factor
1.36 1.41 1.39 1.58 1.53 2.06 3.74 4.68 5.42 21.48 11.84
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 16.91%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 16.91%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
27.42% 29.14% 30.16% 36.83% 37.74% 73.92% -164.94% -148.73% -113.70% -112.66% 46.61%
Common Equity to Total Capital
72.58% 70.86% 69.84% 63.17% 62.26% 26.08% 264.94% 248.73% 213.70% 212.66% 36.48%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.21
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.36
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.21
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.30
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.51
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.30
Altman Z-Score
0.19 -0.19 -0.15 -0.70 -0.33 -1.36 -2.15 -1.25 -1.63 -1.64 0.68
Noncontrolling Interest Sharing Ratio
14.83% 15.42% 16.17% 32.83% 31.77% 41.83% 73.96% 97.89% 112.99% 430.01% 169.99%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.42 3.99 4.06 3.88 3.37 2.80 1.81 1.52 1.24 1.15 2.38
Quick Ratio
2.64 2.44 2.13 1.97 1.95 1.93 1.20 0.85 0.65 0.61 1.05
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-3.96 2.62 3.04 -4.71 6.39 26 56 47 42 23 -47
Operating Cash Flow to CapEx
-16,950.00% -1,066.67% -26,535.00% -3,343.36% 15,765.00% 121,900.00% -115,633.33% -6,490.91% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.64 0.67 0.75 0.68 0.74 0.79 0.82 0.89 0.89 0.85 0.83
Accounts Receivable Turnover
10.88 8.40 10.25 9.90 11.89 10.61 10.46 10.73 11.51 9.38 9.80
Inventory Turnover
1.41 1.54 1.32 1.25 1.54 2.04 1.80 1.66 1.79 1.90 1.63
Fixed Asset Turnover
71.88 67.90 70.24 68.32 84.33 79.66 86.20 88.10 96.01 99.97 111.61
Accounts Payable Turnover
4.80 4.47 4.88 5.18 6.40 5.53 5.01 4.00 3.41 2.51 3.51
Days Sales Outstanding (DSO)
33.55 43.46 35.61 36.87 30.70 34.41 34.89 34.02 31.70 38.92 37.26
Days Inventory Outstanding (DIO)
259.38 237.73 277.15 291.12 236.55 179.03 203.28 219.99 203.36 192.03 223.85
Days Payable Outstanding (DPO)
76.08 81.72 74.85 70.51 57.02 66.03 72.83 91.34 106.93 145.57 104.00
Cash Conversion Cycle (CCC)
216.85 199.47 237.91 257.48 210.24 147.40 165.33 162.67 128.13 85.38 157.11
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
25 23 26 22 18 -3.81 -34 -30 -29 -30 16
Invested Capital Turnover
1.66 1.69 1.54 2.10 2.26 5.69 -15.92 -15.37 -10.71 -3.44 -6.59
Increase / (Decrease) in Invested Capital
1.92 -4.69 -5.03 1.01 -7.26 -26 -60 -52 -47 -26 50
Enterprise Value (EV)
24 29 33 50 48 95 155 149 144 135 77
Market Capitalization
35 39 39 51 53 104 166 155 147 139 72
Book Value per Share
$3.24 $2.97 $2.79 $2.07 $1.96 $0.42 ($1.88) ($1.95) ($2.17) ($2.18) $0.90
Tangible Book Value per Share
$2.23 $1.99 $1.85 $1.50 $1.41 ($0.11) ($2.38) ($2.43) ($2.62) ($2.61) $0.49
Total Capital
50 47 46 37 37 19 -8.36 -9.27 -12 -12 30
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.00
Net Debt
-25 -25 -19 -15 -19 -22 -25 -20 -17 -18 -8.50
Capital Expenditures (CapEx)
0.00 0.05 0.02 0.11 0.02 0.00 0.01 0.08 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
13 11 14 16 9.64 4.52 -3.24 -4.53 -8.17 -12 11
Debt-free Net Working Capital (DFNWC)
38 35 32 30 28 27 22 16 8.70 6.20 25
Net Working Capital (NWC)
38 35 32 30 28 27 22 16 8.70 6.20 25
Net Nonoperating Expense (NNE)
-4.61 1.85 0.16 5.35 0.63 18 23 -2.64 -1.59 -1.99 -34
Net Nonoperating Obligations (NNO)
-25 -25 -19 -15 -19 -22 -25 -20 -17 -18 -8.50
Total Depreciation and Amortization (D&A)
0.88 0.91 0.87 0.83 0.94 1.04 1.03 1.04 1.09 1.16 1.13
Debt-free, Cash-free Net Working Capital to Revenue
31.56% 25.49% 31.64% 34.68% 19.73% 8.45% -5.67% -7.77% -13.81% -20.16% 19.25%
Debt-free Net Working Capital to Revenue
93.41% 82.56% 71.89% 66.18% 56.73% 50.43% 38.57% 27.03% 14.72% 10.60% 42.64%
Net Working Capital to Revenue
93.41% 82.56% 71.89% 66.18% 56.73% 50.43% 38.57% 27.03% 14.72% 10.60% 42.64%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.13 ($0.23) ($0.19) ($0.79) ($0.13) ($1.62) ($2.32) ($0.15) ($0.31) ($0.09) $1.56
Adjusted Weighted Average Basic Shares Outstanding
11.10M 10.97M 11.39M 11.45M 11.60M 11.52M 11.77M 11.94M 12.04M 11.96M 12.16M
Adjusted Diluted Earnings per Share
($0.23) $0.13 ($0.19) ($0.79) ($0.13) ($1.62) ($2.32) ($0.15) ($0.31) ($0.09) $0.00
Adjusted Weighted Average Diluted Shares Outstanding
11.96M 10.97M 11.39M 11.45M 11.60M 11.52M 11.77M 11.94M 12.04M 11.96M 15.42M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
11.25M 11.40M 11.40M 11.61M 11.61M 11.79M 11.79M 11.93M 11.94M 12.10M 12.10M
Normalized Net Operating Profit after Tax (NOPAT)
-1.43 -2.07 -2.00 -1.09 -0.87 -0.90 -4.05 -4.40 -5.31 -3.44 1.57
Normalized NOPAT Margin
-14.58% -17.12% -18.84% -8.59% -6.44% -5.40% -28.62% -31.59% -37.06% -21.49% 11.67%
Pre Tax Income Margin
23.51% -34.36% -22.24% -72.83% -12.22% -112.67% -194.25% -14.04% -26.87% -10.04% 270.57%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

LENSAR’s latest quarter shows a dramatic profitability swing, but the numbers come with some important caveats. In Q1 2026, the company reported revenue of $13.4 million, down from $16.0 million in Q4 2025 and slightly below $14.2 million in Q1 2025. Even so, gross profit remained healthy at $6.4 million, and operating income turned positive at $2.2 million after several quarters of operating losses.

The biggest headline is the sharp jump in net income. LENSAR reported net income of $36.3 million in Q1 2026, compared with a net loss of $1.5 million in Q4 2025 and $27.3 million in loss in Q1 2025. However, this large profit appears to be heavily driven by non-operating income items, including $24.1 million in other income and $10.0 million in interest and investment income. That means the quarter was much stronger on the bottom line than the operating line, but investors should be careful about extrapolating that result.

Operating performance improved, but revenue is still not growing consistently. Revenue in Q1 2026 fell 16.7% sequentially from Q4 2025 and was down 5.7% year over year versus Q1 2025. On the positive side, operating expenses dropped sharply to $4.1 million from $11.9 million in Q4 2025, helping the company reach operating profitability.

Cash flow remains a concern. Despite the reported profit, operating cash flow was negative $4.3 million in Q1 2026, worse than the positive $0.6 million in Q4 2025 and below the negative $6.9 million in Q1 2025. The company also recorded a net cash decline of $0.5 million in the quarter, indicating that earnings quality may not yet be translating into cash generation.

The balance sheet looks liquid, but liabilities are still elevated. As of March 31, 2026, LENSAR held $12.5 million in cash and equivalents and $1.0 million in short-term investments, with total current assets of $42.4 million. Current liabilities were $17.8 million and total liabilities were $41.6 million. The company also had long-term debt of $5.0 million. Current assets still exceed current liabilities, but the margin is not especially wide once you consider the full liability structure.

Recent trends show a transition from losses to more stable operations, but volatility remains high. Over the last several quarters, revenue has generally hovered in the $10 million to $16 million range while operating losses have narrowed at times and widened at others. Q1 2026’s operating income improvement is encouraging, but the quarter’s net income was boosted by large other income items rather than a strong core business turnaround.

  • Operating income turned positive in Q1 2026 at $2.2 million, a meaningful improvement from operating losses in prior quarters.
  • Gross profit remained solid at $6.4 million, showing the business still generates healthy margin before overhead.
  • Cash and investments totaled about $13.5 million at quarter-end, providing some near-term liquidity.
  • Q1 2026 revenue beat the prior year’s Q1 level slightly, rising to $13.4 million from $14.2 million year over year?
  • Large interest and other income boosted reported earnings, but these gains may not recur every quarter.
  • Current assets exceeded current liabilities, which supports short-term balance sheet flexibility.
  • Long-term debt is modest at $5.0 million, but the company still carries substantial noncurrent operating liabilities.
  • Revenue declined sequentially in Q1 2026 from $16.0 million in Q4 2025 to $13.4 million.
  • Operating cash flow was negative $4.3 million, signaling that earnings are not yet producing cash consistently.
  • Net income was heavily dependent on non-operating items, making the quarter’s profitability less representative of core operations.

Bottom line: LENSAR’s Q1 2026 results show real progress at the operating level, but the headline profit was inflated by other income. For retail investors, the key question is whether the company can sustain revenue, continue trimming operating costs, and eventually turn that operating improvement into reliable cash flow.

07/17/26 06:21 AM ETAI Generated. May Contain Errors.

LENSAR Financials - Frequently Asked Questions

According to the most recent income statement we have on file, LENSAR's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

LENSAR's net income appears to be on an upward trend, with a most recent value of -$34.28 million in 2025, rising from -$14.66 million in 2019. The previous period was -$31.40 million in 2024. View LENSAR's forecast to see where analysts expect LENSAR to go next.

LENSAR's total operating income in 2025 was -$24.58 million, based on the following breakdown:
  • Total Gross Profit: $27.12 million
  • Total Operating Expenses: $51.70 million

Over the last 6 years, LENSAR's total revenue changed from $30.53 million in 2019 to $58.44 million in 2025, a change of 91.4%.

LENSAR's total liabilities were at $83.67 million at the end of 2025, a 75.6% increase from 2024, and a 28.5% increase since 2019.

In the past 6 years, LENSAR's cash and equivalents has ranged from $4.62 million in 2019 to $40.60 million in 2020, and is currently $12.97 million as of their latest financial filing in 2025.

Over the last 6 years, LENSAR's book value per share changed from -28.55 in 2019 to -2.18 in 2025, a change of -92.4%.



Financial statements for NASDAQ:LNSR last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners